Drug intelligence / Profile preview

neomycin + bacitracin

Development stage
Unknown
Lead developer
D.A.S.T. BIOTECH PHARM
Modality
Small Molecules, Peptides
Administration
Topical
01

Overview

Vioplex-T is a topical antibacterial combination product formulated as a skin spray powder. It contains two active pharmaceutical ingredients: neomycin sulfate, an aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, and bacitracin, a cyclic polypeptide antibiotic that interferes with bacterial cell wall synthesis by inhibiting the dephosphorylation of C55-isoprenyl pyrophosphate. Developed by D.A.S.T. Biotech Pharm in Greece, the product is indicated for the treatment of bacterial skin and mucosal infections and the prevention of wound infections. It has also been evaluated in a Phase 4 clinical trial for its efficacy and safety in promoting the healing of stage II–III pressure ulcers.

Brand names
Vioplex-T
Other names
neomycin sulfate + bacitracin
02

Targets

Bacterial RibosomeUndecaprenyl pyrophosphate carrier cycleC55-PP (Undecaprenyl pyrophosphate)

Beyond the preview

Go deeper on neomycin + bacitracin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on neomycin + bacitracin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call